High Flow Nasal Cannula Oxygen Therapy Device Micomme Respiratory Support

Micomme Respiratory Support High Flow Nasal Cannula Oxygen Therapy Device

Description

HFNC (often referred to as high-flow) systems are broadly defined as systems that provide an oxygen-gas mixture at flows that meet or exceed a patient’s spontaneous inspiratory effort.

High-flow nasal cannula (HFNC) has become a frequently used non-invasive form of respiratory support in acute settings, however evidence supporting its use has only recently emerged.

High Flow Nasal Cannula (HFNC), isn't just a standard nasal cannula cranked up to very high flow rates. It actually takes gas and can heat it to 37℃ with a 100% relative humidity and can deliver 0.21~1.00% FiO2 at flow rates of up to 70 liters/min. The flow rate and FiO2 can be independently titrated based on your patient's flow and FiO2 requirements.

• Acute hypoxic respiratory failure (ARF) was the first condition treated with HFNC in adults. The use of heated and humidified high flow nasal cannula (HFNC) has become increasingly popular in the treatment of patients with acute respiratory failure through all age groups.
• Post Surgical Respiratory Failure
• Acute Heart Failure /Pulmonary edema
• Hypercapnic Respiratory Failure, COPD
• Obstructive Sleep Apnea

Advantage

At present, micomme occupies over 50% market share in high flow filed in China.

During the pandemic, micomme provided over 7000 units of devices globally.

Unique one-way airway design, no need for disinfection, reducing equipment turnover time and the workload of medical staff.

Effectively reduce the dead space with 70L/min high flow.

Revolutionary trend review function, review the latest 1,3,7 days data of temperature, humidity and O₂ concentration.

Specifications